HR 124 · 119th CongressIn Committeecongress.gov ↗
What this bill does
AI plain-language summaryThis bill would let states get federal money through Medicaid to help pay for teaching people with sickle cell disease about renal medullary carcinoma. The federal government would pay for half of what states spend on this education. Renal medullary carcinoma is a rare kidney disease that usually happens in people with the sickle cell trait.
Your Vote
Discussion (0)
Explain what is at stake in this bill.
Sign in to join the discussion.
No comments yet. Be the first.